Treatment of Heart Failure with Sacubitril/Valsartan in Hondurans with reduced left ventricular ejection fraction: Three-year experience.

Francisco Somoza Alvarenga; Rams&eacute;s  Amaya Handal; César Alas-Pineda; Beatriz Mej&iacute;a Raudales; Juan  Toledo Mart&iacute;nez; Isaac Trejo; Francisco Somoza; Ram&oacute;n Mart&iacute;nez Schweinfurth

International Cardiovascular Research Journal

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Home

Instructions

APC

Authors Guide Submit Manuscript

Treatment of Heart Failure with Sacubitril/Valsartan in Hondurans with reduced left ventricular ejection fraction: Three-year experience.

Author(s):

Francisco Somoza Alvarenga

¹,

Ramsés Amaya Handal

¹,

César Alas-Pineda

^2,*,

Beatriz Mejía Raudales

³,

Juan Toledo Martínez

³,

Isaac Trejo

³,

Francisco Somoza

⁴,

Ramón Martínez Schweinfurth

⁵

1Clínica Ambulatoria CardioCenter, San Pedro Sula, Cortés, Honduras

2Departamento de Epidemiología, Hospital Dr. Mario Catarino Rivas, San Pedro Sula, Cortés, Honduras

3Universidad Católica de Honduras, Campus San Pedro y San Pablo, San Pedro Sula, Cortés, Honduras

4Internal Medicine, St. Vincent Charity Medical Center, Cleveland, USA

5Hospital CEMESA, San Pedro Sula, Cortés, Honduras

International Cardiovascular Research Journal:Vol. 15, issue 4; e118918

Published online:Dec 31, 2021

Article type:Research Article

Received:Aug 21, 2021

Accepted:Dec 25, 2021

How to Cite:Somoza Alvarenga F, Amaya Handal R, Alas-Pineda C, Mejía Raudales B, Toledo Martínez J, et al. Treatment of Heart Failure with Sacubitril/Valsartan in Hondurans with reduced left ventricular ejection fraction: Three-year experience.. Int Cardiovasc Res J. 2021;15(4):e118918. doi:

Abstract

Background: Heart Failure with Reduced Ejection Fraction (HFrEF) is a paramount medical condition affecting more than 23 million individuals worldwide. It is one of the leading causes of morbidity and mortality, particularly in the western world, making it a vital topic of discussion in the current clinical trials.
Objective: This study aimed to describe the response to sacubitril/valsartan in a group of Hondurans with heart failure and reduced Left Ventricular Ejection Fraction (LVEF) between January 2018 and June 2020.
Methods: This observational, descriptive, retrospective cohort study was conducted on 105 adult patients with HFrEF who received treatment with angiotensin-receptor antagonist/neprilysin inhibitors (sacubitril/valsartan) in a single medical center in Honduras. The study participants included the patients with LVEF < 40% treated with sacubitril/valsartan for at least one year. The patients also received optimal medical therapy for HFrEF according to the American Heart Association guidelines. The data were analyzed using the SPSS 25.0 software.
Results: The results showed that the main etiology of HFrEF was ischemic heart disease (41%). The LVEF changed from a median of 30% to 45% after one year of treatment. Additionally, the overall Glomerular Filtration Rate (GFR) remained unchanged. However, the N-Terminal Pro B-type Natriuretic Peptide (NT-ProBNP) decreased from a median of 8800 pg/mL to 1900 pg/mL after 12 months.
Conclusions: The study population had sociodemographic and clinical similarities with the Latin American Cohort in the PARADIGM-HF trial with the significant improvement of the LVEF and functional class. However, the median level of NT-ProBNP was 8800 pg/mL at baseline in the current study, which was dramatically higher than 1760 pg/mL reported in the PARADIGM-HF trial, suggesting the need for further analyses in the Honduran population.

Keywords

Honduras.

Ventricular Ejection Fraction

Heart Failure

Cardiology

Fulltext

The full-text is available in pdf.

References

1.
The references are available in pdf.

Should We Retain Half-Dose ARNIs in HFrEF? Lessons Learned from Reverse Remodeling using CORE-HF Real-World Data

Irnizarifka Irnizarifka,

Irsyad Ristiansah,

Habibie Arifianto,

Trisulo Wasyanto

Irnizarifka I, Ristiansah I, Arifianto H, Wasyanto T. Should We Retain Half-Dose ARNIs in HFrEF? Lessons Learned from Reverse Remodeling using CORE-HF Real-World Data. Int Cardiovasc Res J. 2022;16(3):e129234. doi:

1

Mar

2017

Worsening Renal Function in Acute Decompensated Systolic Heart Failure; Observations from RASHF Registry, an Iranian Heart Failure Registry

Mohammad Hossein Soltani,

Mohammad Javad Alemzadeh-Ansari,

Sepideh Taghavi,

Behshid Ghadrdoost,

Majid Maleki,

Ahmad Amin

,et al.

Soltani MH, Alemzadeh-Ansari MJ, Taghavi S, Ghadrdoost B, Maleki M, et al. Worsening Renal Function in Acute Decompensated Systolic Heart Failure; Observations from RASHF Registry, an Iranian Heart Failure Registry. Int Cardiovasc Res J. 2017;11(1):e10547. doi:

19

Jan

2020

Clinical and Laboratory Predictors of Mortality in Patients with Advanced Heart Failure (Stage D), Data Derived from Rajaie Acute Systolic Heart Failure (RASHF) Data Registry

Rabeah Zamani,

Maryam Chenaghlou,

Zeinab Norouzi,

Mohammad Mostafa Ansari Ramandi,

Sepideh Taghavi,

Ahmad Amin

,et al.

Zamani R, Chenaghlou M, Norouzi Z, Ansari Ramandi MM, Taghavi S, et al. Clinical and Laboratory Predictors of Mortality in Patients with Advanced Heart Failure (Stage D), Data Derived from Rajaie Acute Systolic Heart Failure (RASHF) Data Registry. Multidiscip Cardio Annal. 2020;11(1):e98039. doi: https://doi.org/10.5812/mca.98039

20

Jul

2013

Evaluation of Left Ventricular Systolic Function after Cardiac Resynchronization Therapy in Heart Failure Patients

Zagross Hassaniani,

Jalal Kheirkhah,

Hassan Moladoust,

Hamidreza Bonakdar,

Mohammad Assadian-Rad,

Anoosh Barzigar

,et al.

Hassaniani Z, Kheirkhah J, Moladoust H, Bonakdar H, Assadian-Rad M, et al. Evaluation of Left Ventricular Systolic Function after Cardiac Resynchronization Therapy in Heart Failure Patients. Zahedan J Res Med Sci. 2013;15(9):e92847. doi:

31

Dec

2021

How Guideline Directed Medical Therapy Is Practiced for Patients with Heart Failure? A Cross-Sectional Study in Yazd, Iran

Fatemeh Baridloghmani,

Fatemeh Dana,

Ahmad Shajari,

Elahe Zare,

Mohammadhossein Soltani

Baridloghmani F, Dana F, Shajari A, Zare E, Soltani M. How Guideline Directed Medical Therapy Is Practiced for Patients with Heart Failure? A Cross-Sectional Study in Yazd, Iran. Int Cardiovasc Res J. 2021;15(4):e119179. doi:

Import into EndNote Import into BibTex

Indexed in

Scopus

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 3 weeks ago
Scopus by Title: 0
Last Update: 3 weeks ago
Scopus by Title (Ref): 0
Last Update: 3 weeks ago
CrossRef: 0
Last Update: 2 days ago

Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Francisco Somoza Alvarenga:[PubMed][Scholar]
Ramsés Amaya Handal:[PubMed][Scholar]
César Alas-Pineda:[PubMed][Scholar]
Beatriz Mejía Raudales:[PubMed][Scholar]
Juan Toledo Martínez:[PubMed][Scholar]
Isaac Trejo:[PubMed][Scholar]
Francisco Somoza:[PubMed][Scholar]
Ramón Martínez Schweinfurth:[PubMed][Scholar]

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Outlines

Treatment of Heart Failure with Sacubitril/Valsartan in Hondurans with reduced left ventricular ejection fraction: Three-year experience.

Abstract

Fulltext

References

Similar Articles

Should We Retain Half-Dose ARNIs in HFrEF? Lessons Learned from Reverse Remodeling using CORE-HF Real-World Data

Worsening Renal Function in Acute Decompensated Systolic Heart Failure; Observations from RASHF Registry, an Iranian Heart Failure Registry

Clinical and Laboratory Predictors of Mortality in Patients with Advanced Heart Failure (Stage D), Data Derived from Rajaie Acute Systolic Heart Failure (RASHF) Data Registry

Evaluation of Left Ventricular Systolic Function after Cardiac Resynchronization Therapy in Heart Failure Patients

How Guideline Directed Medical Therapy Is Practiced for Patients with Heart Failure? A Cross-Sectional Study in Yazd, Iran

Last Update: 3 weeks ago

Last Update: 3 weeks ago

Last Update: 3 weeks ago

Last Update: 2 days ago